Brief: Mainz Biomed Establishes Strategic Partnership With TomaLab To Expand Availability Of ColoAlert In Italy
Feb 21 (Reuters) - Mainz Biomed NV 4TO.F :
* MAINZ BIOMED ESTABLISHES STRATEGIC PARTNERSHIP WITH
TOMALAB TO
EXPAND AVAILABILITY OF COLOALERT® IN ITALY
Source text for Eikon: ID:nGNX8NbXl9
Further company coverage: 4TO.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quantum Cyber NV
See all newsBrief: Quantum Cyber To Proceed With Pending Litigation Against Adam Gefvert
Brief: Quantum Cyber NV Files Lawsuit Against White Diamond Research, Adam Gefvert And Stocktwits, Inc. In New York Supreme Court
Quantum Cyber jumps on SpaceX stake purchase plan
Brief: Quantum Cyber Signs Loi To Acquire An Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility To Support Mass-Scale Autonomous Drone Production
Brief: Quantum Cyber NV - To Terminate ATM Sales Agreement With Maxim Effective June 7, 2026 - SEC Filing